What is PD-L1 and Why Should I Be Tested for It?
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The BladderCancer.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- What is a Checkpoint Inhibitor? Insight from Dana-Farber Cancer Institute. https://blog.dana-farber.org/insight/2015/09/what-is-a-checkpoint-inhibitor/ Published September 9, 2015. Accessed September 6, 2019.
- What is PD-L1? Insight from Dana-Farber Cancer Institute. https://blog.dana-farber.org/insight/2017/05/what-is-a-pd-l1-test/ Published May 22, 2017. Accessed September 6, 2019.
- Ghatalia P, Zibelman M, Geynisman DM, & Plimack E. Approved checkpoint inhibitors in bladder cancer: Which drug should be used when? Ther Adv Med Oncol. 2018, 10. Doi: 10.1177/1758835918788310. Accessed September 7, 2019.
- FDA Alters Approved Use of Two Checkpoint Inhibitors for Bladder Cancer. National Cancer Institute. https://www.cancer.gov/news-events/cancer-currents-blog/2018/bladder-cancer-checkpoint-inhibitor-change Published July 26, 2018. Accessed September 7, 2019.
- PD-1/PD-L1 Landscape. Cancer Research Institute. https://www.cancerresearch.org/scientists/immuno-oncology-landscape/pd-1-pd-l1-landscape 2019. Accessed September 9, 2019.